Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $649.60 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $144.18 | 7 | $0 (2019) |
| AbbVie Inc. | $137.01 | 2 | $0 (2020) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $95.89 | 2 | $0 (2023) |
| Amgen Inc. | $75.95 | 1 | $0 (2021) |
| PFIZER INC. | $66.30 | 2 | $0 (2023) |
| UCB, Inc. | $46.17 | 1 | $0 (2023) |
| Incyte Corporation | $37.67 | 2 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $27.96 | 2 | $0 (2019) |
| Lilly USA, LLC | $18.47 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $125.83 | 4 | UCB, Inc. ($46.17) |
| 2022 | $138.67 | 4 | Ortho Dermatologics, a division of Bausch Health US, LLC ($53.77) |
| 2021 | $75.95 | 1 | Amgen Inc. ($75.95) |
| 2020 | $75.92 | 1 | AbbVie Inc. ($75.92) |
| 2019 | $101.04 | 4 | AbbVie, Inc. ($61.09) |
| 2017 | $132.19 | 6 | Celgene Corporation ($132.19) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $46.17 | General |
| Category: Immunology | ||||||
| 10/19/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | TARGRETIN (Drug) | Food and Beverage | In-kind items and services | $42.12 | General |
| Category: Oncology | ||||||
| 03/23/2023 | PFIZER INC. | CIBINQO (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Inflammation & Immunology | ||||||
| 03/21/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: Dermatology | ||||||
| 11/03/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: Dermatology | ||||||
| 10/22/2022 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $45.96 | General |
| 10/20/2022 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $53.77 | General |
| Category: Dermatology | ||||||
| 09/15/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Immunology | ||||||
| 04/22/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $75.95 | General |
| Category: Inflammation | ||||||
| 03/05/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $75.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2019 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $16.51 | General |
| Category: Dermatology | ||||||
| 08/22/2019 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $11.45 | General |
| Category: Dermatology | ||||||
| 07/18/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Dermatology | ||||||
| 05/07/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $61.09 | General |
| Category: Immunology | ||||||
| 11/16/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $3.37 | General |
| 11/15/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $10.54 | General |
| 10/19/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $87.21 | General |
| Category: Dermatology | ||||||
| 10/05/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $15.07 | General |
| 10/05/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $1.40 | General |
| 06/14/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $14.60 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,146 | 1,524 | $324,520 | $46,051 |
| 2022 | 12 | 1,206 | 1,588 | $336,856 | $50,975 |
| 2021 | 12 | 1,408 | 1,897 | $410,151 | $61,807 |
| 2020 | 10 | 1,284 | 1,746 | $331,453 | $43,747 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 361 | 395 | $65,882 | $16,133 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 210 | 239 | $60,498 | $15,530 | 25.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 242 | 276 | $99,212 | $9,391 | 9.5% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 97 | 102 | $54,698 | $1,830 | 3.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Facility | 2023 | 13 | 15 | $14,108 | $1,059 | 7.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 30 | 30 | $3,538 | $714.90 | 20.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 155 | 429 | $12,904 | $609.84 | 4.7% |
| 11104 | Punch biopsy, first skin growth | Facility | 2023 | 11 | 11 | $7,417 | $335.35 | 4.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Facility | 2023 | 16 | 16 | $4,622 | $229.70 | 5.0% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Facility | 2023 | 11 | 11 | $1,641 | $219.04 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 216 | 251 | $59,374 | $16,745 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 377 | 415 | $64,649 | $16,739 | 25.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 235 | 273 | $91,605 | $9,234 | 10.1% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2022 | 109 | 114 | $57,114 | $2,063 | 3.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 21 | 21 | $7,740 | $1,648 | 21.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Facility | 2022 | 14 | 16 | $14,064 | $1,041 | 7.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 32 | 32 | $3,487 | $856.89 | 24.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2022 | 11 | 14 | $7,802 | $709.55 | 9.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 13 | 13 | $3,259 | $635.66 | 19.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2022 | 143 | 401 | $11,280 | $556.72 | 4.9% |
| 11104 | Punch biopsy, first skin growth | Facility | 2022 | 16 | 16 | $10,080 | $428.85 | 4.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Facility | 2022 | 19 | 22 | $6,402 | $316.51 | 4.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 258 | 301 | $68,471 | $20,429 | 29.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 382 | 422 | $63,207 | $17,391 | 27.5% |
| 17000 | Destruction of skin growth | Facility | 2021 | 285 | 344 | $110,992 | $11,384 | 10.3% |
About Dr. Christine Murphy, MD
Dr. Christine Murphy, MD is a Dermatology healthcare provider based in Eau Claire, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205918471.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christine Murphy, MD has received a total of $649.60 in payments from pharmaceutical and medical device companies, with $125.83 received in 2023. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($649.60).
As a Medicare-enrolled provider, Murphy has provided services to 5,044 Medicare beneficiaries, totaling 6,755 services with total Medicare billing of $202,580. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Eau Claire, WI
- Active Since 10/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1205918471
Products in Payments
- Otezla (Drug) $175.15
- SKYRIZI (Biological) $75.92
- Humira (Biological) $61.09
- DUOBRII (Drug) $53.77
- Bimzelx (Biological) $46.17
- TARGRETIN (Drug) $42.12
- OPZELURA (Drug) $37.67
- ILUMYA (Biological) $27.96
- CIBINQO (Drug) $20.34
- TALTZ (Drug) $18.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Eau Claire
Lawrence Scherrer, Md Phd, MD PHD
Dermatology — Payments: $1,962
Dr. Stephanie Tadayon, Md, MD
Dermatology — Payments: $963.76
Elizabeth Demaree, Do, DO
Dermatology — Payments: $539.35
Mary Lou Ernst-Woodhouse, Do, DO
Dermatology — Payments: $195.30
Daniel Jones, Md, MD
Dermatology — Payments: $108.48
Patrice Hicks, Md, MD
Dermatology — Payments: $99.99